Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
12
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Zabrowksi Dan | Director | 2 | $0 | $0 | 2023-08-23 |
| Yang Xiaodong | Chief Executive Officer | 19 | $0 | $0 | 2023-08-23 |
| Wong Amy | SVP, Finance and Operations | 18 | $0 | $0 | 2023-08-23 |
| Hsu Frank J. | Chief Medical Officer | 7 | $0 | $0 | 2023-08-23 |
| Duke William E. | Chief Financial Officer | 9 | $0 | $0 | 2023-08-23 |
| Smith Scott Andrew | Director | 3 | $0 | $0 | 2023-08-23 |
| Dupont Jakob | Director | 4 | $0 | $0 | 2023-08-23 |
| Chhabra Meenu | Director | 2 | $0 | $0 | 2023-08-23 |
| Sarena Francis Willard | President and COO | 8 | $0 | $0 | 2023-08-23 |
| Wertheimer Samuel P | Director | 8 | $0 | $0 | 2023-08-23 |
| CROSS HERB | Director | 3 | $0 | $0 | 2023-08-23 |
| RINGOLD GORDON | Director | 5 | $0 | $0 | 2023-08-23 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 295,978 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 305,000 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 38,417 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 79,906 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 12,296 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 99,373 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 10,000 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 30,734 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 35,856 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 461,015 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 20,489 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 219,950 | — | $0 | 0 | SEC↗ |
| Duke William E. | Chief Financial Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 269,848 | — | $0 | 0 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 27,000 | — | $0 | 0 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | D To issuer deriv | 2023-08-23 | 2023-08-25 | 224,872 | — | $0 | 0 | SEC↗ |
| Sarena Francis Willard | President and COO | D To issuer deriv | 2023-08-23 | 2023-08-25 | 269,847 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer deriv | 2023-08-23 | 2023-08-25 | 22,333 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer deriv | 2023-08-23 | 2023-08-25 | 76,800 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer deriv | 2023-08-23 | 2023-08-25 | 15,366 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer deriv | 2023-08-23 | 2023-08-25 | 71,159 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer deriv | 2023-08-23 | 2023-08-25 | 28,685 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer deriv | 2023-08-23 | 2023-08-25 | 25,611 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer deriv | 2023-08-23 | 2023-08-25 | 8,708 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer deriv | 2023-08-23 | 2023-08-25 | 230,507 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer deriv | 2023-08-23 | 2023-08-25 | 15,367 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer deriv | 2023-08-23 | 2023-08-25 | 13,830 | — | $0 | 0 | SEC↗ |
| CROSS HERB | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 34,084 | — | $0 | 0 | SEC↗ |
| CROSS HERB | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 100,000 | — | $0 | 0 | SEC↗ |
| Dupont Jakob | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 34,084 | — | $0 | 0 | SEC↗ |
| Dupont Jakob | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 100,000 | — | $0 | 0 | SEC↗ |
| Dupont Jakob | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 20,489 | — | $0 | 0 | SEC↗ |
| Chhabra Meenu | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 100,000 | — | $0 | 0 | SEC↗ |
| RINGOLD GORDON | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 5,000 | — | $0 | 0 | SEC↗ |
| RINGOLD GORDON | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 34,084 | — | $0 | 0 | SEC↗ |
| RINGOLD GORDON | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 100,000 | — | $0 | 0 | SEC↗ |
| Smith Scott Andrew | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 100,000 | — | $0 | 0 | SEC↗ |
| Smith Scott Andrew | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 34,084 | — | $0 | 0 | SEC↗ |
| Wertheimer Samuel P | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 1,845 | — | $0 | 0 | SEC↗ |
| Wertheimer Samuel P | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 100,000 | — | $0 | 0 | SEC↗ |
| Wertheimer Samuel P | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 12,383 | — | $0 | 0 | SEC↗ |
| Zabrowksi Dan | Director | D To issuer deriv | 2023-08-23 | 2023-08-25 | 100,000 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | F Tax w/h | 2023-08-23 | 2023-08-25 | 69,161 | $0.39 | $27.0K | 863,729 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | D To issuer | 2023-08-23 | 2023-08-25 | 863,729 | — | $0 | 0 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | A Award | 2023-08-23 | 2023-08-25 | 400,000 | — | $0 | 932,890 | SEC↗ |
| Duke William E. | Chief Financial Officer | D To issuer | 2023-08-23 | 2023-08-25 | 128,001 | — | $0 | 0 | SEC↗ |
| Duke William E. | Chief Financial Officer | F Tax w/h | 2023-08-23 | 2023-08-25 | 26,416 | $0.39 | $10.3K | 128,001 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | D To issuer | 2023-08-23 | 2023-08-25 | 16,354 | — | $0 | 0 | SEC↗ |
| Sarena Francis Willard | President and COO | D To issuer | 2023-08-23 | 2023-08-25 | 124,296 | — | $0 | 0 | SEC↗ |
| Sarena Francis Willard | President and COO | F Tax w/h | 2023-08-23 | 2023-08-25 | 31,123 | $0.39 | $12.1K | 124,296 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | D To issuer | 2023-08-23 | 2023-08-25 | 66,565 | — | $0 | 0 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | F Tax w/h | 2023-08-23 | 2023-08-25 | 15,561 | $0.39 | $6.1K | 66,565 | SEC↗ |
| RINGOLD GORDON | Director | D To issuer | 2023-08-23 | 2023-08-25 | 10,000 | — | $0 | 0 | SEC↗ |
| Wertheimer Samuel P | Director | D To issuer | 2023-08-23 | 2023-08-25 | 146,383 | — | $0 | 0 | SEC↗ |
| Duke William E. | Chief Financial Officer | F Tax w/h | 2023-06-15 | 2023-06-23 | 4,504 | $0.49 | $2.2K | 154,417 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | F Tax w/h | 2023-06-15 | 2023-06-23 | 4,323 | $0.49 | $2.1K | 16,354 | SEC↗ |
| Sarena Francis Willard | President and COO | F Tax w/h | 2023-06-15 | 2023-06-23 | 6,917 | $0.49 | $3.4K | 155,419 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | F Tax w/h | 2023-06-15 | 2023-06-23 | 2,777 | $0.49 | $1.4K | 82,126 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | F Tax w/h | 2023-06-15 | 2023-06-23 | 7,001 | $0.49 | $3.4K | 532,890 | SEC↗ |
| Sarena Francis Willard | President and COO | A Award | 2023-05-23 | 2023-05-25 | 150,000 | — | $0 | 183,084 | SEC↗ |
| Sarena Francis Willard | President and COO | F Tax w/h | 2023-05-23 | 2023-05-25 | 20,748 | $0.40 | $8.3K | 162,336 | SEC↗ |
| Duke William E. | Chief Financial Officer | A Award | 2023-05-23 | 2023-05-25 | 150,000 | — | $0 | 176,182 | SEC↗ |
| Duke William E. | Chief Financial Officer | F Tax w/h | 2023-05-23 | 2023-05-25 | 17,261 | $0.40 | $6.9K | 158,921 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | F Tax w/h | 2023-05-23 | 2023-05-25 | 12,234 | $0.40 | $4.9K | 84,903 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | A Award | 2023-05-23 | 2023-05-25 | 75,000 | — | $0 | 97,137 | SEC↗ |
| Wertheimer Samuel P | Director | J Other deriv | 2023-02-21 | 2023-05-23 | 1,845 | — | $0 | 1,845 | SEC↗ |
| Wertheimer Samuel P | Director | J Other deriv | 2023-01-26 | 2023-05-23 | 12,383 | — | $0 | 12,383 | SEC↗ |
| Wertheimer Samuel P | Director | J Other | 2023-01-26 | 2023-05-23 | 146,383 | — | $0 | 146,383 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | F Tax w/h | 2022-12-15 | 2022-12-19 | 7,001 | $1.06 | $7.4K | 531,391 | SEC↗ |
| Duke William E. | Chief Financial Officer | F Tax w/h | 2022-12-15 | 2022-12-19 | 4,503 | $1.06 | $4.8K | 26,182 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | F Tax w/h | 2022-12-15 | 2022-12-19 | 4,323 | $1.06 | $4.6K | 20,677 | SEC↗ |
| Sarena Francis Willard | Chief Operating Officer | F Tax w/h | 2022-12-15 | 2022-12-19 | 6,916 | $1.06 | $7.3K | 33,084 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | F Tax w/h | 2022-12-15 | 2022-12-19 | 2,851 | $1.06 | $3.0K | 13,637 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | A Award deriv | 2022-10-07 | 2022-10-11 | 305,000 | — | $0 | 305,000 | SEC↗ |
| Duke William E. | Chief Financial Officer | A Award deriv | 2022-10-07 | 2022-10-11 | 269,848 | — | $0 | 269,848 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | A Award deriv | 2022-10-07 | 2022-10-11 | 27,000 | — | $0 | 27,000 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | A Award deriv | 2022-10-07 | 2022-10-11 | 76,800 | — | $0 | 76,800 | SEC↗ |
| Yang Xiaodong | Chief Executive Officer | A Award | 2022-10-07 | 2022-10-11 | 40,488 | — | $0 | 538,392 | SEC↗ |
| Duke William E. | Chief Financial Officer | A Award | 2022-10-07 | 2022-10-11 | 30,685 | — | $0 | 30,685 | SEC↗ |
| Hsu Frank J. | Chief Medical Officer | A Award | 2022-10-07 | 2022-10-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Sarena Francis Willard | Chief Operating Officer | A Award | 2022-10-07 | 2022-10-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Wong Amy | SVP, Finance and Operations | A Award | 2022-10-07 | 2022-10-11 | 16,488 | — | $0 | 16,488 | SEC↗ |
| CROSS HERB | Director | A Award deriv | 2022-09-29 | 2022-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Dupont Jakob | Director | A Award deriv | 2022-09-29 | 2022-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Chhabra Meenu | Director | A Award deriv | 2022-09-29 | 2022-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RINGOLD GORDON | Director | A Award deriv | 2022-09-29 | 2022-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Smith Scott Andrew | Director | A Award deriv | 2022-09-29 | 2022-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Wertheimer Samuel P | Director | A Award deriv | 2022-09-29 | 2022-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Zabrowksi Dan | Director | A Award deriv | 2022-09-29 | 2022-10-03 | 100,000 | — | $0 | 100,000 | SEC↗ |